VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 122 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,154,000 | +120.8% | 327,352 | +61.9% | 0.02% | -7.7% |
| Q1 2015 | $1,881,000 | -53.1% | 202,216 | -27.8% | 0.03% | -61.8% |
| Q4 2014 | $4,010,000 | +124.4% | 280,000 | +62.6% | 0.07% | +83.8% |
| Q3 2014 | $1,787,000 | +123.4% | 172,161 | +248.0% | 0.04% | +105.6% |
| Q2 2014 | $800,000 | -51.5% | 49,466 | -67.1% | 0.02% | -73.1% |
| Q3 2013 | $1,648,000 | – | 150,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |